GRAM Adds Board Member
PTSM: Pharmaceutical Technology Sourcing and Management
Industry veteran Mark Kontny joins board of directors at Grand River Aseptic Manufacturing.
The Grand River Aseptic Manufacturing (GRAM) announced on Nov. 10 2015 that industry veteran Mark Kontny was elected as a member of the the board of directors.
Most recently, Kontny served as president, Pharmaceutical Development Services and chief scientific officer for Patheon. Previously, he served as divisional vice president for Abbott Laboratories, responsible for divisional staffs in Illinois, Massachusetts, Germany, and Singapore. Earlier in his career, Mark spent 10 years at Boehringer Ingelheim, working with the pre-formulation, formulation, and manufacturing of different dosage forms. He became senior director at Pfizer and helped develop small molecules and biologics in both solid-dose and parenteral forms. He worked with a biotech start-up, prior to joining Abbott.
Source: Grand River Aseptic Manufacturing
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
